MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.26, pp.1-7, 2018 (SCI-Expanded)
Background: Knowledge has been expanding on myelin oligodendrocyte glycoprotein (MOG) antibody-associated central nervous system disorders. We delineate the clinical and paraclinical findings and outcome of our pediatric patients with MOG antibody seropositive disease.